References
- Mirrakhimov, A.E. (2015). Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. N. Am. J. Med. Sci. 7(11): 483–93. doi: 10.4103/1947-2714.170600
- Cosman, F., de Beur, S.J., LeBoff, M.S., Lewiecki, E.M., Tanner, B., Randall, S., et al. (2014). Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos. Int. 25(10): 2359–2381. doi: 10.1007/s00198-014-2794-2
- Geng, C.-J., Liang, Q., Zhong, J.-H., Zhu, M., Meng, F.-Y., Wu, N., et al. (2015). Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trials. BMJ Open. 5(6): e007258–e007258. doi: 10.1136/bmjopen-2014-007258
- Mabrouk, M., Hammad, S.F., Abdelaziz, M.A. and Mansour, F.R. (2018). Determination of Etidronate in Pharmaceutical Formulations by RP-HPLC Method with Indirect UV Detection. Arab. J. Med. Sci. 1(2): 1–4.
- Kumar, M.N., Kumar, K.S.R.P., Kumar, V.J., Prasanna, S.J., Sharma, H.K. and Reddy, V.K. (2011). Stability indicating ion chromatography method for the simultaneous determination of ibandronate sodium drug substance and its impurities. J. Pharm. Biomed. Anal. 54(3): 596–601. doi: 10.1016/j.jpba.2010.09.026
- Endele, R., Loew, H. and Bauss, F. (2005). Analytical methods for the quantification of ibandronate in body fluids and bone. J. Pharm. Biomed. Anal. 39(1-2): 246–256. doi: 10.1016/j.jpba.2005.03.020
- Jiang, Y. and Xie, Z. (2005). Determination of Ibandronate and its Degradation Products by Ion-Pair RP LC with Evaporative Light-Scattering Detection. Chromatographia. 62(5–6): 257–261. doi: 10.1365/s10337-005-0618-4
- Tarcomnicu, I., Gheorghe, M.C., Silvestro, L., Savu, S.R., Boaru, I. and Tudoroniu, A. (2009). High-throughput HPLC-MS/MS method to determine ibandronate in human plasma for pharmacokinetic applications. J. Chromatogr. B. 877(27): 3159–3168. doi: 10.1016/j.jchromb.2009.08.007
- Taha, S., Rafat, G., Aboshosha, F. and Mansour, F.R. (2017). A Simple Homemade Spectro-photometer. J. Anal. Chem. 72(2): 239–242. doi: 10.1134/S1061934817020113
- Mabrouk, M., Hammad, S.F., Abdelaziz, M.A. and Mansour, F.R. (2018). Ligand exchange method for determination of mole ratios of relatively weak metal complexes: a comparative study. Chem. Cent. J. 12(1): 143. doi: 10.1186/s13065-018-0512-4
- ICH (2005). ICH Topic Q2 (R1) Validation of Analytical Procedures/ : Text and Methodology. Int. Conf. Harmon. 1994(November 1996): 17.
- Mansour, F.R. and Danielson, N.D. (2012). Ligand exchange spectrophotometric method for the determination of mole ratio in metal complexes. Microchem. J. 103: 74–78. doi: 10.1016/j.microc.2012.01.008
- Mansour, F.R., Shafi, M.A. and Danielson, N.D. (2012). Flow injection determination of carboxylate, phosphate, and sulfhydryl compounds using metal exchange complexation. Talanta. 95: 12–7. doi: 10.1016/j.talanta.2012.03.017
- Pérez-Ruiz, T., Martínez-Lozano, C. and García-Martínez, M.D. (2009). A sensitive post-column photochemical derivatization/fluorimetric detection system for HPLC determination of bisphosphonates. J. Chromatogr. A. 1216(9): 1312–1318. doi: 10.1016/j.chroma.2008.12.051
- Elmalla, S.F. and Mansour, F.R. (2019). A simple innovative spectrofluorometric method for the determination of alendronate in bulk and in pharmaceutical tablets. Luminescence: bio.3622doi: 10.1002/bio.3622.